Biogen Newsroom

Biogen Price Target Maintained With a $292.00/Share by RBC Capital

Dow JonesSep 19 21:26

Biogen Analyst Ratings

BenzingaSep 19 21:17

RBC Capital Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $292

Futu NewsSep 19 19:33

RBC Capital Keeps Their Buy Rating on Biogen (BIIB)

TipRanksSep 19 18:47

Cantor Fitzgerald Reiterates Overweight on Biogen, Maintains $292 Price Target

BenzingaSep 9 23:29

Biogen Analyst Ratings

BenzingaSep 9 23:28

BMO Capital Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $260

Futu NewsSep 5 19:31

Optimistic Buy Rating for Biogen on Strategic Cost-Cutting and Growth Asset Prioritization

TipRanksSep 5 19:01

Biogen Price Target Maintained With a $285.00/Share by Needham

Dow JonesSep 4 18:35

Needham Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $285

Futu NewsSep 4 18:31

Biogen Analyst Ratings

BenzingaSep 4 18:25

Biogen's Upward Trajectory: A Buy Rating on Alzheimer's and Pipeline Progress

TipRanksSep 4 18:20

Oppenheimer Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $270

Futu NewsSep 3 20:31

Oppenheimer Reaffirms Their Buy Rating on Biogen (BIIB)

TipRanksSep 3 19:51

Needham Reiterates Buy on Biogen, Maintains $285 Price Target

BenzingaAug 19 17:32

Needham Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $285

Futu NewsAug 19 17:32

Biogen Analyst Ratings

BenzingaAug 19 17:31

The latest pharmaceutical industry rating by S&P reveals that Johnson & Johnson (JNJ.US) and Roche (RHHBY.US) are ranked at the top for superior financial and innovative abilities.

Zhitong FinanceAug 19 11:30

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB)

TipRanksAug 12 01:04

Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $251

Futu NewsAug 6 19:38